Skip to content

Study · Not a test of the peptide alone · 2015

3 results

Chrono- and Immunocorrection of Inflammatory Disorders of Internal Reproductive Organs in Women of Reproductive Age.

Litvinenko GI, Shurlygina AV, Dergacheva TI, Mel'nikova EV, Trufakin VA

Bulletin of experimental biology and medicine1 May 2015

PMID26033592 (opens in a new tab)DOI10.1007/s10517-015-2890-0 (opens in a new tab)PepBankPUB-26033592
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialOther

    In women with chronic salpingitis and oophoritis, most patients given ridostin or thymalin during a lymphocyte SDH reaction to the drug showed improved clinical laboratory and immunological parameters.

    In plain wordsIn women with chronic salpingitis and oophoritis, most patients given ridostin or thymalin during a cell reaction to it improved on clinical and immune measures.

    Peptide
    Thymalin
    Outcome
    IncreaseClinical laboratory and immunological improvement
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    In the groups of women receiving ridostin or thymalin during the reaction of lymphocyte SDH to it, improvement of clinical laboratory and immunological parameters was observed in the majority of the patients
    1 context sentence
    Summary · context
    We compared the effectiveness of immunomodulators used in the treatment of patients with chronic salpingitis and oophoritis with or without changes in succinate dehydrogenase (SDH) activity in blood lymphocytes at incubation with the drug.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialOther

    In women with chronic salpingitis and oophoritis, pooled ridostin or thymalin treatment during SDH reactivity left fewer patients without an effect.

    In plain wordsIn women, pooled ridostin or thymalin treatment during cellular reactivity left fewer patients without benefit than treatment during absent reactivity.

    Peptide
    Thymalin
    Outcome
    DecreaseProportion with no effect
    Study

    n: not reported in source

    Comparator
    Treatment during absence of lymphocyte SDH reaction
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    and no effect was found in a lesser group of patients than in the groups treated with drugs during the absence of lymphocyte SDH reaction thereto.
    2 context sentences
    Summary · context
    In the groups of women receiving ridostin or thymalin during the reaction of lymphocyte SDH to it, improvement of clinical laboratory and immunological parameters was observed in the majority of the patients
    Summary · context
    We compared the effectiveness of immunomodulators used in the treatment of patients with chronic salpingitis and oophoritis with or without changes in succinate dehydrogenase (SDH) activity in blood lymphocytes at incubation with the drug.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03LabNot a test of Thymalin aloneEx vivo tissueOther

    In blood lymphocytes from women with chronic salpingitis and oophoritis, SDH responses to thymalin or ridostin varied by time of day.

    In plain wordsIn lab tests of blood lymphocytes, responses to thymalin or ridostin varied by time of day.

    Peptide
    Thymalin
    Outcome
    MixedDiurnal SDH reaction
    Study

    n: not reported in source

    Blood lymphocytes from women with chronic salpingitis and oophoritis
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Diurnal variations in individual reaction of SDH in blood lymphocytes to thymalin or ridostin were revealed.
    1 context sentence
    Summary · context
    We compared the effectiveness of immunomodulators used in the treatment of patients with chronic salpingitis and oophoritis with or without changes in succinate dehydrogenase (SDH) activity in blood lymphocytes at incubation with the drug.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.